Voyager Therapeutics
VYGR
VYGR
98 hedge funds and large institutions have $418M invested in Voyager Therapeutics in 2017 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+23
Holders Change %
+30.67%
% of All Funds
2.23%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
40
Increased
37
Reduced
16
Closed
17
Calls
$1.84M
Puts
$1.26M
Net Calls
+$580K
Net Calls Change
-$3.01M
Top Buyers
1 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
$25.6M |
2 |
BlackRock
New York
|
$20.1M |
3 |
FCM
Farallon Capital Management
San Francisco,
California
|
$10.9M |
4 |
LCM
Laurion Capital Management
New York
|
$7.68M |
5 |
Axa
Paris,
France
|
$5.59M |